STOCK PURCHASE AGREEMENTStock Purchase Agreement • February 6th, 2024 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 6th, 2024 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT (this “Agreement”) is entered into as of February 6, 2024 (the “Effective Date”), between Lineage Cell Therapeutics, Inc., a California corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).